Allergan Announces Death of Stephen J. Ryan, M.D.
Dr. Ryan Was Internationally Recognized Expert in Retinal Disease and Ocular Trauma and Member of the Allergan Board of Directors
IRVINE, Calif.--(BUSINESS WIRE)-- Allergan, Inc., (NYSE: AGN ) today announced that Stephen J. Ryan, M.D., a member of the Allergan Board of Directors, died on April 29th,2013 after a short illness. Dr. Ryan was 72 years old.
“Steve, in all his modesty, was one of the greatest retinal surgeons and worldwide ophthalmic experts and, in fact, trained many of today’s global leaders in ophthalmology,” said David E.I. Pyott, Chairman, President, and Chief Executive Officer, Allergan. “As a member of the Allergan Board of Directors, Steve served the Company and the Board with unwavering loyalty and insight, and a commitment to corporate fiduciary duties, ethics and stewardship. As a scientific leader, he was passionate about sharing his knowledge and supporting Allergan’s R&D efforts to advance our robust pipeline and bring new therapies to market. During our many years of working together, I have valued Steve’s perspective and guidance. All of us who have had the privilege of working with Steve will miss him greatly, not only as a colleague, but as a friend.”
Dr. Ryan was an internationally recognized expert in the field of retinal disease and ocular trauma. Last year, Dr. Ryan was recognized as a Laureate of the American Academy of Ophthalmology, the Academy’s single highest honor and one that has been awarded to only a few individuals. Dr. Ryan served as President of the Doheny Eye Institute and as the Distinguished Grace and Emery Beardsley Professor of Ophthalmology at the Keck School of Medicine of the University of Southern California. He was the Dean of the Keck School of Medicine and Senior Vice President for Medical Care of the University of Southern California for 13 years and was also a long-standing member of the Institute of Medicine of the National Academy of Sciences. Dr. Ryan was the founding President of the National Alliance for Eye and Vision Research, and a member and director of the W.M. Keck Foundation and a member of the Arnold and Mabel Beckman Foundation.
Dr. Ryan joined the Allergan Board of Directors in 2002. During his tenure as a member of the Allergan Board of Directors, Dr. Ryan served as Chairman of the Board’s Science and Technology Committee and as a member of the Audit and Finance Committee. In January 2013, Dr. Ryan announced his retirement from the Allergan Board of Directors, effective at the annual stockholders’ meeting on April 30th, 2013.
KEYWORDS: United States North America California